Literature DB >> 19021060

Polymorphisms of tumor-necrosis factor-alpha - 308 and lymphotoxin-alpha + 250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells.

Tatjana Jevtovic-Stoimenov1, Gordana Kocic, Dusica Pavlovic, Lana Macukanovic-Golubovic, Goran Marjanovic, Vidosava Djordjevic, Natasa Tosić, Sonja Pavlović.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) and lymphotoxin alpha (LT-alpha) have been shown to play an important role in the pathogenesis of limphoproliferative disease. Both cytokines regulate cell-survival and cell-death in leukemic cells. TNF-alpha and LT-alpha are highly produced in chronic lymphotic leukemia (CLL) and non-Hodgkin lymphoma (NHL) patients. Genetic polymorphism within regulatory regions of these cytokine genes can alter their expression levels. This study investigates an influence of TNF-alpha - 308 and LT-alpha + 250 polymorphisms on the activity of alkaline DNase in mononuclear cells of both patient groups as a potent biochemical marker of DNA fragmentation in the terminal phase of apoptosis. Study was performed on mononuclear cells of CLL and NHL patients. SNP were obtained by PCR-RFLP method. The activity of alkaline DNase was measured by spectrophotometric method. The study provided evidence of the influence of TNFG/A genotype and A alleles in the susceptibility to NHL, since the association of LT-alphaG/G genotype with CLL was observed. High-producing TNF-alpha - 308/LT-alpha + 250 heterozygous haplotype is associated with high NHL incidence. The investigated SNP influence the activity of alkaline DNase in CLL and NHL patients. The observed polymorphisms may modulate susceptibility of leukemic cells to apoptosis by way of DNase activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19021060     DOI: 10.1080/10428190802381220

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  Prognostic importance of single-nucleotide polymorphisms in IL-6, IL-10, TGF-β1, IFN-γ, and TNF-α genes in chronic phase chronic myeloid leukemia.

Authors:  Mustafa Pehlivan; Handan Haydaroglu Sahin; Sacide Pehlivan; Kursat Ozdilli; Leylagul Kaynar; Fatma Savran Oguz; Tugce Sever; Mehmet Yilmaz; Bulent Eser; Yeliz Duvarci Ogret; Cem Kis; Vahap Okan; Mustafa Cetin; Mahmut Carin
Journal:  Genet Test Mol Biomarkers       Date:  2014-05-12

2.  Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia.

Authors:  Anna Balato; Serena Lembo; Teresa Cirillo; Matteo Megna; Annunziata Raimondo; Luisa Di Costanzo
Journal:  Case Rep Dermatol       Date:  2011-03-07

3.  Different role of tumor necrosis factor-α polymorphism in non-Hodgkin lymphomas among Caucasian and Asian populations: a meta-analysis.

Authors:  Kan Zhai; Jie Ding; Yan Zhou
Journal:  Int J Mol Sci       Date:  2014-05-05       Impact factor: 5.923

4.  Association of TNF-α rs1800629 with Adult Acute B-Cell Lymphoblastic Leukemia.

Authors:  Ezeldine K Abdalhabib; Abdulrahman Algarni; Muhammad Saboor; Fehaid Alanazi; Ibrahim K Ibrahim; Ayman H Alfeel; Abdullah M Alanazi; Abdulmajeed M Alanazi; Abdulaziz M Alruwaili; Muath H Alanazi; Nahla A Alshaikh
Journal:  Genes (Basel)       Date:  2022-07-13       Impact factor: 4.141

5.  The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis.

Authors:  Yong-Qiao He; Jin-Hong Zhu; Shao-Yi Huang; Zhuo Cui; Jing He; Wei-Hua Jia
Journal:  Tumour Biol       Date:  2014-09-10

6.  Lack of Association of Tumor Necrosis Factor-α G-308A and Transforming Growth Factor-β1 C-509T Polymorphisms in Patients with Deep Neck Space Infections.

Authors:  T Jevtović-Stoimenov; M Despotović; Z Pešić; A Cosić
Journal:  Balkan J Med Genet       Date:  2013-12       Impact factor: 0.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.